Keywords
Type 2 diabetes mellitus
Continuous glucose monitoring
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To compare the effectiveness of continuous glucose monitoring (CGM) with traditional treatments for type 2 diabetes mellitus. Methods: This is an integrative literature review carried out through the PubMED, Virtual Health Library (VHL) and CAPES Periodical databases, using the descriptors: “Adults”, “Continuous Glucose Monitoring”, “Diabetes Mellitus, Type 2” and “Treatment Outcome” and obtaining the search truncation: (Continuous Glucose Monitoring) AND (Diabetes Mellitus, Type 2) AND (Treatment Outcome) AND (Adults). A total of 1,104 articles were found, filtered according to inclusion criteria (Portuguese, English and Spanish; period from 2019 to 2024; full articles) and exclusion criteria (duplicate articles, abstracts, out of scope). Results: CGM allows real-time monitoring, reducing episodes of hypoglycemia and improving glycemic control, although the high cost is a challenge. Combined with telemedicine, CGM improves treatment adherence and patients’ quality of life. In contrast, traditional methods face limitations such as inaccuracy and discomfort of daily punctures, affecting treatment adherence and efficacy. Conclusion: CGM is superior to traditional methods, offering greater accuracy and comfort. Its adoption, with health policies and adequate training, can transform the management of type 2 diabetes, providing more effective and personalized care.
References
ALICE Y, et al. Blood glucose monitoring in adults and children with diabetes: Update 2021. Canadian journal of diabetes, 2021; 45(7): 580–587.
ARADÓTTIR TB, et al. Feasibility of a new approach to initiate insulin in type 2 diabetes. Journal of diabetes science and technology, 2021; 15(2): 339–345.
BAKER M, et al. Practical implementation of remote continuous glucose monitoring in hospitalized patients with diabetes. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists, 2022; 79(6): 452–458.
CASTELLANA M, et al. Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. BMJ open diabetes research & care, 2020; 8(1): 001092.
CHAO C, et al. Assessing non-adjunctive CGM safety at home and in new markets (ANSHIN). Endocrinology, diabetes & metabolism, 2023; 6(3): 414.
DIXON RF, et al. A virtual type 2 diabetes clinic using continuous glucose monitoring and endocrinology visits. Journal of diabetes science and technology, 2020; 14(5): 908–911.
EHRHARDT N, et al. Effectiveness of a culturally tailored diabetes education curriculum with real-time continuous glucose monitoring in a Latinx population with type 2 diabetes: the CUT-DM with CGM for Latinx randomised controlled trial study protocol. BMJ open, 2023; 13(12): 82005.
GERBER BS, et al. Mobile health intervention in patients with type 2 diabetes: A randomized clinical trial. JAMA network open, 2023; 6(9): 2333629.
HAAK T, et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: A multicenter, open-label randomized controlled trial. Diabetes therapy: research, treatment and education of diabetes and related disorders, 2017; 8(1): 55–73.
JANCEV M, et al. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetologia, 2024; 67(5): 798–810.
KARTER AJ, et al. Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes. JAMA: the journal of the American Medical Association, 2021; 325(22): 2273–2284.
KAWAGUCHI Y, et al. Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U‐100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring. Journal of diabetes investigation, 2024; 15(5): 598–607.
LIND N, et al. Peer support for adults with type 2 diabetes starting continuous glucose monitoring-An exploratory randomised controlled trial. Diabetic medicine: a journal of the British Diabetic Association, 2024; 41(6): 15321.
LIND N, et al. Real-time continuous glucose monitoring versus self-monitoring of blood glucose in adults with insulin-treated type 2 diabetes: a protocol for a randomised controlled single-centre trial. BMJ open, 2021; 11(1): 40648.
MATSUOKA A, et al. Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: A multicenter cross-sectional study. Journal of diabetes investigation, 2020; 11(2): 417–425.
MUNAN M, et al. Acute and chronic effects of exercise on continuous glucose monitoring outcomes in type 2 diabetes: A meta-analysis. Frontiers in endocrinology, 2020; 11: 495.
OSER TK, et al. Personal continuous glucose monitoring use among adults with type 2 diabetes: Clinical efficacy and economic impacts. Current diabetes reports, 2021; 21(11).
RIBEIRO RT, et al. Impact of blinded retrospective continuous glucose monitoring on clinical decision making and glycemic control in persons with type 2 diabetes on insulin therapy. Nutrition, metabolism, and cardiovascular diseases: NMCD, 2021; 31(4): 1267–1275.
RIVERA-ÁVILA DA, et al. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes. BMC endocrine disorders, 2021; 21(1): 79.
RUAN Y, et al. Association of body fat percentage with time in range generated by continuous glucose monitoring during continuous subcutaneous insulin infusion therapy in type 2 diabetes. Journal of diabetes research, 2021; 2021: 1–9.
SINGH LG, et al. Continuous glucose monitoring in general wards for prevention of hypoglycemia: Results from the glucose telemetry system pilot study. Journal of diabetes science and technology, 2020; 14(4): 783–790.
TAYLOR PJ, et al. Effectiveness and acceptability of continuous glucose monitoring for type 2 diabetes management: A narrative review. Journal of diabetes investigation, 2028; 9(4): 713–725.
YAJIMA T, et al., Comparison of interstitial fluid glucose levels obtained by continuous glucose monitoring and flash glucose monitoring in patients with type 2 diabetes mellitus undergoing hemodialysis. Journal of diabetes science and technology, 2020; 14(6): 1088–1094.
ZHENG M, et al. Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol. Systematic reviews, 2020; 9(1).